Related references
Note: Only part of the references are listed.Liver Diseases Associated with Anti-Tumor Necrosis Factor-alpha (TNF-alpha) Use for Inflammatory Bowel Disease
Carla S. Coffin et al.
INFLAMMATORY BOWEL DISEASES (2011)
Gastrointestinal and liver adverse effects of drugs used for treating IBD
Gerhard Rogler
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Hepatopancreatobiliary Manifestations and Complications Associated with Inflammatory Bowel Disease
Udayakumar Navaneethan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland
Helen Steed et al.
OBESITY FACTS (2009)
Complications and functional results after ileoanal pouch formation in obese patients
R. P. Kiran et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Anti-tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis:: a retrospective cohort study
P. Gisondi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
Rosita Saraceno et al.
PHARMACOLOGICAL RESEARCH (2008)
Adalimumab Could Suppress the Activity of Non Alcoholic Steatohepatitis (NASH)
C. Schramm et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2008)
The treatment with antibody of TNF-α reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet
Suleyman Serdar Koca et al.
INFLAMMATION (2008)
Liver injury in inflammatory Bowel disease:: Long-term follow-up study of 786 patients
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2007)
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
Raquel Barbuio et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines
Shivakumar Chitturi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Abnormal hepatic biochemistries in patients with inflammatory bowel disease
Flavia D. Mendes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The impact of increased body mass index on the clinical course of Crohn's disease
DJ Hass et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Impact of infliximab on serum leptin levels in patients with Crohn's disease
D Franchimont et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
SK Satapathy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: Study of 511 subjects at a single center
S Bargiggia et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation
M Candelli et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Crohn's disease clinical course and severity in obese patients
A Blain et al.
CLINICAL NUTRITION (2002)
Share Paper
